276 related articles for article (PubMed ID: 33981003)
1. Nuclear localisation of Aurora-A: its regulation and significance for Aurora-A functions in cancer.
Naso FD; Boi D; Ascanelli C; Pamfil G; Lindon C; Paiardini A; Guarguaglini G
Oncogene; 2021 Jun; 40(23):3917-3928. PubMed ID: 33981003
[TBL] [Abstract][Full Text] [Related]
2. Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy.
Yan M; Wang C; He B; Yang M; Tong M; Long Z; Liu B; Peng F; Xu L; Zhang Y; Liang D; Lei H; Subrata S; Kelley KW; Lam EW; Jin B; Liu Q
Med Res Rev; 2016 Nov; 36(6):1036-1079. PubMed ID: 27406026
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of mitotic interaction between the nucleoporin Tpr and aurora kinase A.
Kobayashi A; Hashizume C; Dowaki T; Wong RW
Cell Cycle; 2015; 14(9):1447-58. PubMed ID: 25789545
[TBL] [Abstract][Full Text] [Related]
4. Aurora A Protein Kinase: To the Centrosome and Beyond.
Magnaghi-Jaulin L; Eot-Houllier G; Gallaud E; Giet R
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30650622
[TBL] [Abstract][Full Text] [Related]
5. Aurora kinase A inhibitors: promising agents in antitumoral therapy.
Malumbres M; PĂ©rez de Castro I
Expert Opin Ther Targets; 2014 Dec; 18(12):1377-93. PubMed ID: 25200357
[TBL] [Abstract][Full Text] [Related]
6. An update on the pharmacokinetics and pharmacodynamics of alisertib, a selective Aurora kinase A inhibitor.
Durlacher CT; Li ZL; Chen XW; He ZX; Zhou SF
Clin Exp Pharmacol Physiol; 2016 Jun; 43(6):585-601. PubMed ID: 26999067
[TBL] [Abstract][Full Text] [Related]
7. Phosphatase 1 Nuclear Targeting Subunit (PNUTS) Regulates Aurora Kinases and Mitotic Progression.
Wang F; Wang L; Fisher LA; Li C; Wang W; Peng A
Mol Cancer Res; 2019 Jan; 17(1):10-19. PubMed ID: 30190438
[TBL] [Abstract][Full Text] [Related]
8. Issues in interpreting the in vivo activity of Aurora-A.
Shagisultanova E; Dunbrack RL; Golemis EA
Expert Opin Ther Targets; 2015 Feb; 19(2):187-200. PubMed ID: 25384454
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype.
Lentini L; Amato A; Schillaci T; Di Leonardo A
BMC Cancer; 2007 Nov; 7():212. PubMed ID: 17999753
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells.
Leontovich AA; Salisbury JL; Veroux M; Tallarita T; Billadeau D; McCubrey J; Ingle J; Galanis E; D'Assoro AB
Oncol Rep; 2013 May; 29(5):1785-8. PubMed ID: 23446853
[TBL] [Abstract][Full Text] [Related]
11. Advances in Aurora kinase inhibitor patents.
Coumar MS; Cheung CH; Chang JY; Hsieh HP
Expert Opin Ther Pat; 2009 Mar; 19(3):321-56. PubMed ID: 19441907
[TBL] [Abstract][Full Text] [Related]
12. The centrosomal adaptor TACC3 and the microtubule polymerase chTOG interact via defined C-terminal subdomains in an Aurora-A kinase-independent manner.
Thakur HC; Singh M; Nagel-Steger L; Kremer J; Prumbaum D; Fansa EK; Ezzahoini H; Nouri K; Gremer L; Abts A; Schmitt L; Raunser S; Ahmadian MR; Piekorz RP
J Biol Chem; 2014 Jan; 289(1):74-88. PubMed ID: 24273164
[TBL] [Abstract][Full Text] [Related]
13. Aurora A kinase (AURKA) in normal and pathological cell division.
Nikonova AS; Astsaturov I; Serebriiskii IG; Dunbrack RL; Golemis EA
Cell Mol Life Sci; 2013 Feb; 70(4):661-87. PubMed ID: 22864622
[TBL] [Abstract][Full Text] [Related]
14. Biology of Aurora A kinase: implications in cancer manifestation and therapy.
Karthigeyan D; Prasad SB; Shandilya J; Agrawal S; Kundu TK
Med Res Rev; 2011 Sep; 31(5):757-93. PubMed ID: 20196102
[TBL] [Abstract][Full Text] [Related]
15. Aurora A regulates the architecture of the Golgi apparatus.
Kimura M; Takagi S; Nakashima S
Exp Cell Res; 2018 Jun; 367(1):73-80. PubMed ID: 29571950
[TBL] [Abstract][Full Text] [Related]
16. AIBp regulates mitotic entry and mitotic spindle assembly by controlling activation of both Aurora-A and Plk1.
Chou CH; Loh JK; Yang MC; Lin CC; Hong MC; Cho CL; Chou AK; Wang CH; Lieu AS; Howng SL; Hsu CM; Hong YR
Cell Cycle; 2015; 14(17):2764-76. PubMed ID: 26114227
[TBL] [Abstract][Full Text] [Related]
17. Dynamic association of a tumor amplified kinase, Aurora-A, with the centrosome and mitotic spindle.
Stenoien DL; Sen S; Mancini MA; Brinkley BR
Cell Motil Cytoskeleton; 2003 Jun; 55(2):134-46. PubMed ID: 12740874
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Characterization of Derrone as an Aurora Kinase Inhibitor.
Hoang NT; Phuong TT; Nguyen TT; Tran YT; Nguyen AT; Nguyen TL; Bui KT
Biol Pharm Bull; 2016 Jun; 39(6):935-45. PubMed ID: 26983907
[TBL] [Abstract][Full Text] [Related]
19. Insights into the non-mitotic functions of Aurora kinase A: more than just cell division.
Bertolin G; Tramier M
Cell Mol Life Sci; 2020 Mar; 77(6):1031-1047. PubMed ID: 31562563
[TBL] [Abstract][Full Text] [Related]
20. Aurora A Kinase Is a Priority Pharmaceutical Target for the Treatment of Cancers.
Damodaran AP; Vaufrey L; Gavard O; Prigent C
Trends Pharmacol Sci; 2017 Aug; 38(8):687-700. PubMed ID: 28601256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]